NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
2.67
Dollar change
-0.06
Percentage change
-2.20
%
IndexRUT P/E- EPS (ttm)-0.93 Insider Own12.61% Shs Outstand127.54M Perf Week-3.61%
Market Cap340.58M Forward P/E- EPS next Y-0.77 Insider Trans0.00% Shs Float111.47M Perf Month-11.88%
Enterprise Value199.44M PEG- EPS next Q-0.21 Inst Own65.99% Short Float28.80% Perf Quarter3.49%
Income-107.48M P/S70.66 EPS this Y7.58% Inst Trans14.94% Short Ratio9.94 Perf Half Y-13.03%
Sales4.82M P/B1.71 EPS next Y11.17% ROA-42.37% Short Interest32.10M Perf YTD1.91%
Book/sh1.56 P/C2.27 EPS next 5Y3.62% ROE-48.98% 52W High6.33 -57.82% Perf Year-26.65%
Cash/sh1.18 P/FCF- EPS past 3/5Y5.67% -29.30% ROIC-52.82% 52W Low2.01 32.84% Perf 3Y-20.30%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-1.76% 17.09% Gross Margin-170.92% Volatility6.32% 6.17% Perf 5Y-
Dividend TTM- EV/Sales41.38 EPS Y/Y TTM20.78% Oper. Margin-2349.30% ATR (14)0.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.72 Sales Y/Y TTM-9.95% Profit Margin-2232.13% RSI (14)46.51 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.72 EPS Q/Q4.25% SMA20-1.87% Beta2.03 Target Price9.12
Payout- Debt/Eq0.04 Sales Q/Q31.29% SMA50-4.36% Rel Volume0.90 Prev Close2.73
Employees157 LT Debt/Eq0.02 EarningsMay 13 AMC SMA200-19.72% Avg Volume3.23M Price2.67
IPOJul 22, 2021 Option/ShortYes / Yes EPS/Sales Surpr.6.12% -21.52% Trades Volume2,899,998 Change-2.20%
Date Action Analyst Rating Change Price Target Change
Jul-03-25Resumed Morgan Stanley Overweight $7
Jan-22-25Initiated Needham Buy $9
Oct-02-24Initiated Guggenheim Buy $10
Jul-03-24Initiated Morgan Stanley Overweight $7
Mar-14-24Initiated Scotiabank Sector Outperform $13
Dec-05-23Initiated KeyBanc Capital Markets Overweight $3
May-04-23Initiated H.C. Wainwright Buy $4
Aug-12-22Downgrade JP Morgan Overweight → Underweight
Jul-18-22Initiated Truist Buy $8
Mar-02-22Resumed Cowen Market Perform
Jul-11-25 07:15PM
Jul-07-25 08:30AM
08:00AM
May-20-25 08:00AM
May-14-25 08:32AM
03:17AM Loading…
03:17AM
May-13-25 05:30PM
04:05PM
04:01PM
May-12-25 09:35AM
Apr-14-25 04:05PM
11:40AM
Apr-03-25 03:15PM
Mar-31-25 07:15AM
Mar-26-25 08:00AM
10:57PM Loading…
Mar-21-25 10:57PM
Mar-19-25 09:08AM
03:03AM
Mar-18-25 04:05PM
Mar-04-25 04:05PM
04:00PM
08:00AM
Mar-01-25 05:19PM
Feb-18-25 08:00AM
Feb-12-25 09:24AM
Feb-11-25 09:00AM
Jan-24-25 11:54AM
Jan-22-25 01:22PM
08:00AM
Jan-17-25 05:58PM
01:54PM Loading…
01:54PM
Jan-11-25 07:40AM
Jan-10-25 05:48PM
07:30AM
Jan-08-25 01:14PM
09:12AM
07:00AM
06:32AM
Jan-06-25 08:00AM
Jan-02-25 08:00AM
Dec-30-24 02:39PM
Dec-13-24 08:10AM
Dec-12-24 08:00AM
08:00AM
Nov-21-24 08:00AM
Nov-20-24 09:15AM
Nov-13-24 02:07AM
Nov-12-24 09:23PM
08:50AM
07:30AM
Nov-11-24 07:15AM
Nov-07-24 08:00AM
Oct-31-24 08:00AM
Oct-24-24 08:00AM
Oct-15-24 08:00AM
Aug-31-24 02:37PM
Aug-30-24 10:30AM
Aug-21-24 08:00AM
Aug-14-24 05:30PM
04:01PM
Aug-12-24 08:00AM
Jul-31-24 04:25AM
Jul-10-24 08:00AM
Jul-03-24 04:00PM
Jun-21-24 11:08AM
Jun-12-24 08:00AM
May-28-24 08:00AM
May-20-24 09:32PM
May-16-24 07:15AM
May-15-24 03:01AM
May-14-24 11:53AM
07:30AM
May-12-24 03:26PM
May-07-24 09:13AM
Apr-16-24 08:00AM
Apr-10-24 11:07AM
Mar-28-24 04:05PM
Mar-23-24 05:31AM
Mar-21-24 02:52PM
07:30AM
Mar-12-24 05:34PM
Mar-06-24 06:34AM
Mar-01-24 04:01PM
06:49AM
Feb-27-24 10:20PM
04:01PM
Feb-21-24 07:30AM
Feb-20-24 08:00AM
Feb-05-24 09:40AM
Jan-10-24 07:30AM
Jan-08-24 07:00AM
Jan-03-24 08:00AM
Dec-28-23 08:00AM
Dec-20-23 07:30AM
Dec-05-23 08:11AM
Dec-04-23 07:30AM
06:18AM
Dec-03-23 01:27AM
01:22AM
12:21AM
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.